Testing effectiveness (Phase 2)Ended earlyNCT00573755
What this trial is testing
Sorafenib and Letrozole, Anastrozole, or Exemestane in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Metastatic Breast Cancer
Who this might be right for
Breast Cancer
Mayo Clinic 4